Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Recombinant DNA01:09

Recombinant DNA

96.2K
Overview
96.2K
The Central Dogma01:20

The Central Dogma

23.3K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
23.3K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in the association of lipoprotein(a) with subclinical coronary atherosclerosis in asymptomatic individuals.

Journal of cardiology·2026
Same author

Association of Toothbrushing, Dental Flossing, and Interdental Brushing with Stroke Risk.

Journal of dentistry·2026
Same author

Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.

Diabetes, obesity & metabolism·2026
Same author

Body mass index variability and pancreatic cancer risk in South Korean adults: a nationwide cohort study.

Korean journal of family medicine·2026
Same author

Effects of dietary xylanase supplementation on growth performance and gut health of weaned pigs fed a high non-starch polysaccharides diet.

Journal of animal science and technology·2026
Same author

Diagnostic and therapeutic methods in equine and canine rehabilitation.

Journal of the American Veterinary Medical Association·2026

Related Experiment Video

Updated: Aug 22, 2025

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

25.9K

Recombinant mucin biotechnology and engineering.

Sangwoo Park1, Joe Chin-Hun Kuo2, Heidi L Reesink3

  • 1Field of Biophysics, Cornell University, Ithaca, NY 14853, USA.

Advanced Drug Delivery Reviews
|November 14, 2022
PubMed
Summary
This summary is machine-generated.

Engineered mucins, leveraging genetic encoding and advanced glycan tuning, offer versatile biomaterials and therapeutics. These advancements unlock new possibilities for biomedical applications and drug development.

Keywords:
BiomaterialBiopolymerDrug deliveryGlycanLubricationMucinRecombinant

More Related Videos

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.1K
Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
08:43

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

7.6K

Related Experiment Videos

Last Updated: Aug 22, 2025

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

25.9K
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.1K
Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
08:43

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

7.6K

Area of Science:

  • Biomaterials Science
  • Glycobiology
  • Biotechnology

Background:

  • Mucins are a rich, yet underutilized, source of polymeric building blocks.
  • Their genetically encoded backbone allows for sequence-specific fabrication using recombinant technologies.
  • Pendient O-glycans on mucins play crucial roles in immunomodulation and pathogen interaction.

Purpose of the Study:

  • To review recent advances in engineered mucins.
  • To highlight opportunities for mucin-based biomaterials and therapeutics.
  • To discuss strategies for tuning mucin glycan structures and functionality.

Main Methods:

  • Recombinant technologies for fabricating sequence-specific mucins.
  • Engineered cell production systems for scalable synthesis.
  • Metabolic and chemoenzymatic strategies for mucin O-glycan tuning and functionalization.

Main Results:

  • Scalable synthesis of recombinant mucins with precisely controlled glycan side chains is now possible.
  • Advanced glycan engineering allows for expanded chemical diversity and tailored biological functionality.
  • Engineered mucins show promise for diverse biomedical applications.

Conclusions:

  • Engineered mucins represent a promising platform for developing novel biomaterials and therapeutics.
  • Precise control over mucin structure and glycosylation enables the design of functional biomolecules.
  • Further exploration of engineered mucins will drive innovation in biotechnology and medicine.